These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
594 related articles for article (PubMed ID: 18813856)
1. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells. Yang M; Huang J; Pan HZ; Jin J Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856 [TBL] [Abstract][Full Text] [Related]
2. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells. Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312 [TBL] [Abstract][Full Text] [Related]
3. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors. Pei XY; Dai Y; Grant S Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093 [TBL] [Abstract][Full Text] [Related]
4. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754 [TBL] [Abstract][Full Text] [Related]
5. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance. Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102 [TBL] [Abstract][Full Text] [Related]
6. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin. Sun ZJ; Chen G; Hu X; Zhang W; Liu Y; Zhu LX; Zhou Q; Zhao YF Apoptosis; 2010 Jul; 15(7):850-63. PubMed ID: 20386985 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells. Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494 [TBL] [Abstract][Full Text] [Related]
8. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235. McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292 [TBL] [Abstract][Full Text] [Related]
10. The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines. Strauss SJ; Higginbottom K; Jüliger S; Maharaj L; Allen P; Schenkein D; Lister TA; Joel SP Cancer Res; 2007 Mar; 67(6):2783-90. PubMed ID: 17363600 [TBL] [Abstract][Full Text] [Related]
11. PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma. Wang W; Hayashi J; Serrero G Clin Cancer Res; 2006 Jan; 12(1):49-56. PubMed ID: 16397023 [TBL] [Abstract][Full Text] [Related]
12. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172 [TBL] [Abstract][Full Text] [Related]
13. Naphtho[1,2-b]furan-4,5-dione induces apoptosis of oral squamous cell carcinoma: involvement of EGF receptor/PI3K/Akt signaling pathway. Chien CM; Lin KL; Su JC; Chuang PW; Tseng CH; Chen YL; Chang LS; Lin SR Eur J Pharmacol; 2010 Jun; 636(1-3):52-8. PubMed ID: 20371243 [TBL] [Abstract][Full Text] [Related]
14. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Hideshima T; Richardson P; Chauhan D; Palombella VJ; Elliott PJ; Adams J; Anderson KC Cancer Res; 2001 Apr; 61(7):3071-6. PubMed ID: 11306489 [TBL] [Abstract][Full Text] [Related]
15. Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. Meister S; Schubert U; Neubert K; Herrmann K; Burger R; Gramatzki M; Hahn S; Schreiber S; Wilhelm S; Herrmann M; Jäck HM; Voll RE Cancer Res; 2007 Feb; 67(4):1783-92. PubMed ID: 17308121 [TBL] [Abstract][Full Text] [Related]
16. Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myeloma. von Metzler I; Heider U; Mieth M; Lamottke B; Kaiser M; Jakob C; Sezer O Exp Cell Res; 2009 Aug; 315(14):2471-8. PubMed ID: 19410573 [TBL] [Abstract][Full Text] [Related]
17. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells. Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088 [TBL] [Abstract][Full Text] [Related]
18. The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance. Maiso P; Carvajal-Vergara X; Ocio EM; López-Pérez R; Mateo G; Gutiérrez N; Atadja P; Pandiella A; San Miguel JF Cancer Res; 2006 Jun; 66(11):5781-9. PubMed ID: 16740717 [TBL] [Abstract][Full Text] [Related]
19. Role of triptolide in cell proliferation, cell cycle arrest, apoptosis and histone methylation in multiple myeloma U266 cells. Zhao F; Chen Y; Zeng L; Li R; Zeng R; Wen L; Liu Y; Zhang C Eur J Pharmacol; 2010 Nov; 646(1-3):1-11. PubMed ID: 20547150 [TBL] [Abstract][Full Text] [Related]
20. Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling. Haake SM; Dinh CT; Chen S; Eshraghi AA; Van De Water TR Hear Res; 2009 Sep; 255(1-2):22-32. PubMed ID: 19442713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]